Dr. Cyr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5225 Mid America Plz
# Dv
Saint Louis, MO 63129Phone+1 800-647-2098Fax+1 314-362-3192
Summary
- Dr. Amy Cyr is a breast health specialist in Saint Louis, MO. She received her medical degree from University of Nebraska College of Medicine and completed general surgery training at New Hanover Regional Medical Center in Wilmington, NC. She then completed a breast surgical oncology fellowship at Washington University. She is an Assistant Professor of Surgery at Washington University and has been in practice 15 years. She specializes in breast cancer genetics and management of patients with elevated breast cancer risk. She sees patients at Siteman Cancer Center at Barnes Jewish Hospital.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Breast Surgical Oncology, 2009 - 2010
- Novant Health New Hanover Regional Medical CenterResidency, Surgery, 2002 - 2007
- University of Nebraska College of MedicineClass of 2002
Certifications & Licensure
- IL State Medical License 2019 - 2026
- MO State Medical License 2009 - 2025
- OK State Medical License 2020 - 2020
- NC State Medical License 2002 - 2007
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow American College of Surgeons
Clinical Trials
- LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer Start of enrollment: 2014 Apr 01
- Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Start of enrollment: 2013 Dec 19
- Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy Start of enrollment: 2013 Apr 04
- Join now to see all
Publications & Presentations
PubMed
- 225 citationsNeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.Cynthia X. Ma, Feng Gao, Jingqin Luo, Donald W. Northfelt, Matthew P. Goetz
Clinical Cancer Research. 2017-08-01 - 8 citationsPredictors of false negative axillary ultrasound in breast cancerIheoma Nwaogu, Yan Yan, Catherine M. Appleton, Amy E. Cyr, Julie A. Margenthaler
The Journal of Surgical Research. 2015-10-01 - 144 citationsBreast cancer, version 1.2016 featured updates to the NCCN guidelinesWilliam J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein
Journal of the National Comprehensive Cancer Network. 2015-12-01
Press Mentions
- Shedding Light on Family History and Cancer Risk | for Your HealthNovember 3rd, 2022
- NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study FindsJune 16th, 2017
- Ace the Case: Diagnostic Workup of Bloodstream Infection in a 12-Year-Old Adolescent with Septic ShockOctober 1st, 2021
Committees
- Member, Membership Committee, ASBS 2015 - Present
- Member, Research Committee, ASBS 2015 - 2018
- Member, Research Committee, SSO 2015 - 2018
- Member, Editorial Board, Breast Section, Annals of Surgical Oncology 2015 - 2018
Professional Memberships
- Member
- Member
- Member
- Member
- American Medical Writers AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: